In summary with respect to the question of cART timing within the first two months of TB therapy, our study from low-income and high TB/HIV prevalent setting showed cART one week after TB therapy does not improve all-cause mortality rate in coinfected patients with CD4 count < 200 cells/μL compared with four and eight weeks. The gene discussed is CD4; the disease is tuberculosis.